Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Cancer statistics, 2022
2022 Standout
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
2013 Standout
Cancer statistics, 2023
2023 Standout
Breast cancer
2019 Standout
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 Standout
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
2018 Standout
The Swedish cause of death register
2017 Standout
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients
2007
Anorectal Dysfunction Increases with Time Following Radiation Therapy for Carcinoma of the Prostate
2004
Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial
2012
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated With Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease
2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
2011
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
2000 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Child and parental mental ability and glycaemic control in children with Type 1 diabetes
2001
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
2009
Ethical aspects of registry-based research in the Nordic countries
2015
Prostate cancer
2015
Epidemiology of Prostate Cancer
2019 Standout
Literacy and health outcomes
2004 Standout
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
2020
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980–2007
2010
Global cancer statistics
2011 Standout
Prostate cancer incidence and mortality trends in 37 European countries: An overview
2010
Duration of Androgen Suppression in the Treatment of Prostate Cancer
2009
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
2003
Gleason Pattern 5 Is the Greatest Risk Factor for Clinical Failure and Death From Prostate Cancer After Dose-Escalated Radiation Therapy and Hormonal Ablation
2011
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2015 Standout
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function
2000
Registers of the Swedish total population and their use in medical research
2016 Standout
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
2009
Local treatment of metastatic cancer—killing the seed or disturbing the soil?
2011
Cervical cancer
2019 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Molecular Mechanisms of Late Normal Tissue Injury
2007
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
2016
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
2016
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study
1999
Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case–Control Study within PCBaSe Sweden
2013
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
2002
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
2000
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
2011
Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy
2005
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
Traditional androgen ablation approaches to advanced prostate cancer: new insights.
2014
Works of Per Fransson being referenced
Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population
1994
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
2008
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019
Relations between age, metabolic control, disease adjustment and psychological aspects in insulin‐dependent diabetes mellitus
1996
Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
2012
Self-assessed sexual function after pelvic irradiation for prostate carcinoma: Comparison with an age-matched control group
1996
Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma
2001
Health-related quality of life 10 years after external beam radiotherapy or watchful waiting in patients with localized prostate cancer
2008
Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma
1999
Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects.
2001